抗精神病药物的使用与严重精神疾病患者 COVID-19 死亡率之间的关联。
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness.
机构信息
Department of Psychiatry, New York University Langone Medical Center, New York.
Nathan Kline Institute for Psychiatric Research, Orangeburg, New York.
出版信息
JAMA Psychiatry. 2021 Dec 1;78(12):1391-1393. doi: 10.1001/jamapsychiatry.2021.2503.
Abstract
This cohort study investigates whether an association exists between antipsychotic use and mortality in patients with serious mental illness who are diagnosed with COVID-19.
摘要
这项队列研究旨在调查在诊断患有 COVID-19 的严重精神疾病患者中，使用抗精神病药物是否与死亡率之间存在关联。
相似文献
1
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness.
JAMA Psychiatry. 2021 Dec 1;78(12):1391-1393. doi: 10.1001/jamapsychiatry.2021.2503.
2
Clozapine Toxicity in the Setting of COVID-19.
Psychosomatics. 2020 Sep-Oct;61(5):577-578. doi: 10.1016/j.psym.2020.05.025. Epub 2020 May 30.
3
Relapse in patients with serious mental disorders during the COVID-19 outbreak: a retrospective chart review from a community mental health center.
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):381-383. doi: 10.1007/s00406-020-01203-1. Epub 2020 Oct 26.
4
Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness.
Acta Psychiatr Scand. 2015 Mar;131(3):213-22. doi: 10.1111/acps.12345. Epub 2014 Oct 14.
5
An overall protective effect of antipsychotic drugs against COVID-19 seems implausible.
Schizophr Res. 2022 May;243:486-488. doi: 10.1016/j.schres.2021.12.020. Epub 2021 Dec 22.
6
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
7
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data.
Adv Ther. 2018 Oct;35(10):1612-1625. doi: 10.1007/s12325-018-0785-y. Epub 2018 Sep 11.
8
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.
JAMA Netw Open. 2022 May 2;5(5):e2210743. doi: 10.1001/jamanetworkopen.2022.10743.
9
Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.
Psychol Med. 2017 Oct;47(14):2483-2493. doi: 10.1017/S0033291717001040. Epub 2017 Apr 26.
10
Is antipsychotic medication stigmatizing for people with mental illness?
Int Rev Psychiatry. 2007 Apr;19(2):107-12. doi: 10.1080/09540260701278911.
引用本文的文献
1
Adherence to Antipsychotics, COVID-19 and Stigma: A Rainbow After the Storm?
Actas Esp Psiquiatr. 2025 May;53(3):616-620. doi: 10.62641/aep.v53i3.1813.
2
COVID-19 vaccination attitudes and acceptance among people with serious mental illness.
Front Psychiatry. 2025 Jan 22;15:1535780. doi: 10.3389/fpsyt.2024.1535780. eCollection 2024.
3
Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.
Int J Neuropsychopharmacol. 2024 Apr 1;27(4). doi: 10.1093/ijnp/pyae020.
4
Research Letter: Effect of antivirals for COVID-19 on the mortality of older adults dispensed treatment with lithium, antipsychotics, antidepressants, anxiolytics and hypnotics.
Aust N Z J Psychiatry. 2024 Feb;58(2):183-186. doi: 10.1177/00048674231217700. Epub 2023 Dec 12.
5
COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.
Epidemiol Psychiatr Sci. 2023 Oct 20;32:e61. doi: 10.1017/S2045796023000719.
6
COVID-19 vaccine acceptance and related behavioral and psychological characteristics in individuals with mental disorders in Korea.
Front Psychiatry. 2023 May 16;14:1195103. doi: 10.3389/fpsyt.2023.1195103. eCollection 2023.
7
Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.
Gen Hosp Psychiatry. 2023 May-Jun;82:1-6. doi: 10.1016/j.genhosppsych.2023.01.014. Epub 2023 Feb 3.
8
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis.
Eur Neuropsychopharmacol. 2023 Jan;66:30-44. doi: 10.1016/j.euroneuro.2022.10.004. Epub 2022 Oct 20.
9
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.
Pharmaceutics. 2022 Aug 30;14(9):1828. doi: 10.3390/pharmaceutics14091828.
10
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health.
Eur Psychiatry. 2022 Aug 16;65(1):e47. doi: 10.1192/j.eurpsy.2022.2307.
Zotero 插件